Free Trial
NASDAQ:AMRN

Amarin (AMRN) Stock Price, News & Analysis

Amarin logo
$15.54 +0.08 (+0.48%)
As of 10:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Amarin Stock (NASDAQ:AMRN)

Key Stats

Today's Range
$15.03
$15.59
50-Day Range
$12.54
$17.33
52-Week Range
$7.08
$17.49
Volume
18,972 shs
Average Volume
93,033 shs
Market Capitalization
$321.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Reduce

Company Overview

Amarin Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

AMRN MarketRank™: 

Amarin scored higher than 5% of companies evaluated by MarketBeat, and ranked 933rd out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Amarin has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Amarin has only been the subject of 2 research reports in the past 90 days.

  • Read more about Amarin's stock forecast and price target.
  • Earnings Growth

    Earnings for Amarin are expected to decrease in the coming year, from ($0.15) to ($0.27) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Amarin is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Amarin is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Amarin has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Amarin's valuation and earnings.
  • Percentage of Shares Shorted

    2.31% of the float of Amarin has been sold short.
  • Short Interest Ratio / Days to Cover

    Amarin has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Amarin has recently increased by 15.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Amarin does not currently pay a dividend.

  • Dividend Growth

    Amarin does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.31% of the float of Amarin has been sold short.
  • Short Interest Ratio / Days to Cover

    Amarin has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Amarin has recently increased by 15.20%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Amarin has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Amarin this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for AMRN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Amarin to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Amarin insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.30% of the stock of Amarin is held by insiders.

  • Percentage Held by Institutions

    Only 22.25% of the stock of Amarin is held by institutions.

  • Read more about Amarin's insider trading history.
Receive AMRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarin and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMRN Stock News Headlines

Chase, Bank of America, Wells Fargo Preparing for BIG Change
Thanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in America could soon begin to replace every single dollar in your bank account… With a better, more technologically advanced dollar… Potentially making a lot of people rich in the process.tc pixel
Amarin Reports Second Quarter 2025 Financial Results
Amarin Q2 2025 Earnings Preview
AMRN - Amarin Corp PLC ADR Key Metrics - Morningstar
See More Headlines

AMRN Stock Analysis - Frequently Asked Questions

Amarin's stock was trading at $9.70 at the beginning of 2025. Since then, AMRN stock has increased by 59.5% and is now trading at $15.47.

Amarin Corporation PLC (NASDAQ:AMRN) released its earnings results on Wednesday, July, 30th. The biopharmaceutical company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.66) by $0.63. The biopharmaceutical company had revenue of $72.74 million for the quarter, compared to the consensus estimate of $45.45 million. Amarin had a negative net margin of 47.22% and a negative trailing twelve-month return on equity of 21.18%.
Read the conference call transcript
.

Amarin's stock reverse split before market open on Friday, April 11th 2025.The 1-20 reverse split was announced on Wednesday, March 12th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 10th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Amarin subsidiaries include Ester Neurosciences, Amarin France SAS, Amarin Germany GmbH, Amarin Italy S.r.l, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc., Amarin Switzerland GmbH, Amarin UK Limited, and Ester Neurosciences Limited.

Amarin's top institutional shareholders include Acadian Asset Management LLC (1.16%), SCP Investment LP (0.60%), Waterfront Wealth Inc. (0.46%) and BNP Paribas Financial Markets (0.37%). Insiders that own company stock include Aaron Berg, Steven B Ketchum and Patrick Holt.
View institutional ownership trends
.

Shares of AMRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amarin investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
7/30/2025
Today
8/28/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AMRN
CIK
897448
Fax
N/A
Employees
360
Year Founded
1991

Price Target and Rating

High Price Target
$12.00
Low Price Target
$12.00
Potential Upside/Downside
-22.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$82.18 million
Net Margins
-47.22%
Pretax Margin
-44.91%
Return on Equity
-21.18%
Return on Assets
-15.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.26
Quick Ratio
2.34

Sales & Book Value

Annual Sales
$228.61 million
Price / Sales
1.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$22.45 per share
Price / Book
0.69

Miscellaneous

Outstanding Shares
20,710,000
Free Float
20,024,000
Market Cap
$320.38 million
Optionable
Optionable
Beta
0.84

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:AMRN) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners